Valuation: Cipla Limited

Market Cap 1,08600Cr 1.13TCr 1TCr 936.6Cr 853.68Cr 1.61TCr 1.63TCr 11TCr 4.39TCr 56TCr 4.24TCr 4.15TCr 1,78100Cr P/E 2027 *
26.2x
P/E 2028 * 21.1x
Enterprise Value 98TCr 1.02TCr 905.46Cr 845.1Cr 770.28Cr 1.45TCr 1.47TCr 10TCr 3.96TCr 50TCr 3.83TCr 3.74TCr 1,60700Cr EV / Sales 2027 *
3.16x
EV / Sales 2028 * 2.75x
Free-Float
68.87%
Yield 2027 *
0.97%
Yield 2028 * 1.1%
1 day-0.71%
1 week-4.11%
Current month-0.71%
1 month-4.76%
3 months-8.50%
6 months+9.38%
Current year-16.67%
1 week 14
Extreme 14
14.5
1 month 14
Extreme 14
14.8
Current year 12.8
Extreme 12.8
17
1 year 12.8
Extreme 12.8
18.9
3 years 12.8
Extreme 12.8
20
5 years 10.4
Extreme 10.4
20
10 years 4.94
Extreme 4.94
20
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Director of Finance/CFO - 24/07/2026
President - 18/05/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%-4.11% - - 1.13TCr
-0.61%-3.43%+36.07%+117.61% 1,01900Cr
-1.02%-5.60%+35.72%+64.82% 62TCr
+1.11%-0.58%+12.36%+78.27% 46TCr
+0.34%-3.01%+61.79%+41.79% 36TCr
-0.95%-4.05%+20.54%+40.33% 33TCr
-1.46%-2.89%+10.57%+26.54% 27TCr
-1.35%-5.43%-6.17%+8.82% 24TCr
-1.04%-2.79%+35.30%+54.42% 22TCr
-1.87%-4.10%+28.44%+97.54% 18TCr
Average -0.76%-3.39%+26.07%+58.90% 41.08TCr
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2027 *2028 *
Net sales 31TCr 322.35Cr 286.41Cr 267.32Cr 243.65Cr 459.52Cr 463.8Cr 3.23TCr 1.25TCr 16TCr 1.21TCr 1.18TCr 51TCr 35TCr 361.34Cr 321.05Cr 299.65Cr 273.12Cr 515.11Cr 519.9Cr 3.63TCr 1.41TCr 18TCr 1.36TCr 1.33TCr 57TCr
Net income 4.14TCr 43Cr 38Cr 36Cr 33Cr 61Cr 62Cr 431.72Cr 167.29Cr 2.11TCr 161.51Cr 158.01Cr 6.78TCr 5.14TCr 53Cr 48Cr 44Cr 40Cr 76Cr 77Cr 536.83Cr 208.02Cr 2.63TCr 200.84Cr 196.48Cr 8.44TCr
Net Debt -11TCr -110.34Cr -98Cr -92Cr -83Cr -157.29Cr -158.76Cr -1.11TCr -429.09Cr -5.42TCr -414.27Cr -405.28Cr -17TCr -13TCr -136.73Cr -121.49Cr -113.39Cr -103.35Cr -194.92Cr -196.73Cr -1.37TCr -531.72Cr -6.72TCr -513.36Cr -502.22Cr -22TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change
01/26/01 $14.00 -0.71%
30/26/30 $14.10 -2.08%
29/26/29 $14.40 -0.69%
28/26/28 $14.50 -0.68%
25/26/25 $14.60 0.00%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,344.00INR
Average target price
1,509.08INR
Spread / Average Target
+12.28%

Quarterly revenue - Rate of surprise